Mississauga, ON -- (SBWIRE) -- 03/12/2015 -- AllPennyStocks.com Media, Inc. (http://www.AllPennyStocks.com/) announces its latest article titled "OncoSec Medical Reports Financial Results For Six-Month Period Ended January 31, 2015."
Companies mentioned in this article include iShares NASDAQ Biotechnology Index (ETF) (NASDAQ:IBB) and OncoSec Medical Inc. (OTCQB:ONCS).
The biotechnology sector has been off to a solid start in 2015, with the iShares NASDAQ Biotechnology Index (ETF) (NASDAQ: IBB) gaining nearly 12.50% year-to-date. Investors' interest in the biotechnology sector remains high.
One of the areas within the biotechnology sector that has generated the most interest is cancer therapy as there is still significant unmet medical need in this area. A number of biotechnology companies, as well as large pharmas are conducting research in the field of cancer therapy at this time.
Immunotherapy has emerged as a promising therapy for the dreaded disease. The National Cancer Institute (NCI) describes immunotherapies as "treatments that restore or enhance the immune system's ability to fight cancer." The NCI further states that in recent years they have seen the emergence of a number of new methods of treating cancer that boost the strength of immune responses against tumors.
In 2013, the journal Science designated "immunotherapy of cancer" as its Breakthrough of the Year, according to the NCI.
An emerging player in the field of immunotherapy is OncoSec Medical Inc. (OTCQB:ONCS). Based in San Diego, California, ONCS is engaged in the design, development and commercialization of proprietary medical approaches, mainly immunotherapy, to treat advanced-stage skin cancer.
The full version of this article can be found at:
AllPennyStocks.com is focused on the small-cap / penny stock market and has become a reputable name in the investment community. AllPennyStocks.com runs a Canadian and US site to provide investors in Canada as well as the United States with informative and unique content and information. AllPennyStocks.com runs daily technical penny stocks to watch, has a daily market write-up, provides company spotlights, runs unique most active pages strictly for penny stocks trading on the TSX, TSX Venture, NASDAQ and OTC BB, and much more information for the average investor.
AllPennyStocks.com also runs an email newsletter that aims to uncover stocks that are still under the radar of most investors. Criteria AllPennyStocks.com looks for includes strong revenues, a seasoned management, innovative business plans, among many others. AllPennyStocks.com also looks for companies that announce breaking news, recent 52-week highs/lows, technical breakouts, and other favorable corporate information.
Investors are encouraged to subscribe to the AllPennyStocks.com FREE e-mail newsletter and see what tens of thousands of other investors have already been receiving since 1999. Investors can receive their free newsletter subscription by clicking here: http://www.allpennystocks.com/aps_common/newsletter_free.asp.
AllPennyStocks.com Media, Inc.
Peter Szafranski -- President
Phone: (905) 361-5680
Websites: http://www.allpennystocks.com / http://www.bullishinvestor.com
Note: AllPennyStocks.com has not received compensation for carrying the above-mentioned company; a full disclaimer can be viewed here: http://www.allpennystocks.com/aps_common/disclaimer.asp.